Please visit the Coronavirus Resource Center . We are actively monitoring the situation and will keep this site updated with the latest policies and information.

Dr. Cheng Chen, left, and Dr. Kenneth Jacobs, second from right, Bryent Tucker, Taylor Forbes and Dr. Xin-Hua Hu. (File Photos by Cliff Hollis)

For the first time, a company started by East Carolina University faculty members has received a Phase II Small Business Technology Transfer (STTR) grant from the National Institutes of Health.

RFPi, a Greenville medical device company, was awarded $1.49 million for continued development of technology that will be used to evaluate patients with peripheral arterial disease (PAD), a subset of vascular disease that affects blood flow to the lower extremities.

Patients with PAD are at increased risk for heart attack or stroke; left untreated, the condition can lead to the loss of a leg. About 20 million patients in the United States have PAD.

Read More


Originally published Oct. 9, 2019.


Accessibility options

Adjust the interface to make it easier to use for different conditions.
This renders the document in high contrast mode.
This renders the document as white on black
This can help those with trouble processing rapid screen movements.
This loads a font easier to read for people with dyslexia.